News for Healthier Living

Receptor.AI and Sethera Therapeutics Form Integrated Discovery Alliance for AI-Guided Polymacrocyclic Peptide Medicines

Under the collaboration, Sethera will generate and experimentally screen architecture-diverse polymacrocyclic peptide libraries. Receptor.AI will apply physics-based modeling, artificial intelligence, and multiparameter optimization to interpret sequence, architecture, enrichment, and activity data; develop binding hypotheses; prioritize candidate series; and guide focused optimization cycles.

August 3, 2026


August 4 2026

August 3 2026

August 1 2026

July 31 2026

July 30 2026

July 29 2026

July 28 2026

July 27 2026

July 26 2026

July 25 2026

July 24 2026

July 23 2026

July 22 2026

July 21 2026